- Home
- SATX vs TIL Comparison
SATX vs TIL Comparison
Compare SATX & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATX
- TIL
- Stock Information
- Founded
- SATX 2012
- TIL 2018
- Country
- SATX Israel
- TIL United States
- Employees
- SATX N/A
- TIL N/A
- Industry
- SATX Radio And Television Broadcasting And Communications Equipment
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- SATX Technology
- TIL Health Care
- Exchange
- SATX Nasdaq
- TIL Nasdaq
- Market Cap
- SATX 175.9M
- TIL 171.7M
- IPO Year
- SATX N/A
- TIL 2021
- Fundamental
- Price
- SATX $2.90
- TIL $26.95
- Analyst Decision
- SATX Strong Buy
- TIL Buy
- Analyst Count
- SATX 2
- TIL 5
- Target Price
- SATX $2.25
- TIL $119.00
- AVG Volume (30 Days)
- SATX 718.8K
- TIL 316.4K
- Earning Date
- SATX 05-22-2025
- TIL 05-13-2025
- Dividend Yield
- SATX N/A
- TIL N/A
- EPS Growth
- SATX N/A
- TIL N/A
- EPS
- SATX N/A
- TIL N/A
- Revenue
- SATX $23,654,000.00
- TIL N/A
- Revenue This Year
- SATX $50.67
- TIL N/A
- Revenue Next Year
- SATX $1.64
- TIL N/A
- P/E Ratio
- SATX N/A
- TIL N/A
- Revenue Growth
- SATX 130.79
- TIL N/A
- 52 Week Low
- SATX $0.58
- TIL $9.62
- 52 Week High
- SATX $2.97
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- SATX 87.38
- TIL 65.08
- Support Level
- SATX $2.87
- TIL $12.60
- Resistance Level
- SATX $2.92
- TIL $35.28
- Average True Range (ATR)
- SATX 0.03
- TIL 3.84
- MACD
- SATX 0.05
- TIL 1.60
- Stochastic Oscillator
- SATX 92.47
- TIL 63.27
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd is engaged in developing end-to-end next-generation satellite communication systems. This includes satellite payloads, user terminals, and modems, which are built on powerful in-house designed chipsets. Their products feature modems equipped with Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the entire DVB-RCS2 / DVB-S2X industry standards as well as a complete SDR for any other waveform. The company has a geographical presence in the U.S. & Canada, the UK, and Other countries, with the majority of its revenue generated from the U.S. and Canada.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.